Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
Data on immunotherapy discussed by researchers at University of Genoa, Department of Internal Medicine
March 25th, 2008
A report, 'Immunotherapy with dendritic cells for cancer,' is newly published data in Advanced Drug Delivery Reviews. According to a study from Genoa, Italy, "Dendritic cells are professional antigen-presenting cells with a key role in both immunity induction and tolerance maintenance. Dendritic cells are highly specialized in antigen capture, processing and presentation, and express co-stimulation signals which activate T lymphocytes and NK cells." "Dendritic cells generated in culture and loaded with an antigen efficiently induce antigen-specific immunity after injection. More recently, methods have been developed that target antigens to dendritic cells in...
Source: Cancer Weekly (2008-03-25)
|
